Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism S1PR1 agonists(Sphingosine 1-phosphate receptor Edg-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H23ClF3N3O3 |
InChIKeyFAXWYINFZCBJBO-UHFFFAOYSA-N |
CAS Registry3028594-26-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | China | 01 Dec 2025 | |
| Multiple Sclerosis | Preclinical | China | 01 Dec 2025 |





